 This study is an open-label, single center, and a single arm phase II study to evaluate the clinical response and safety of perioperative S-1 plus docetaxel. Perioperative chemotherapy is composed of 3 cycles of preoperative S-1docetaxel and 3 cycles of postoperative S-1docetaxel.Chemotherapy regimen: 